BRUZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 13.898
EU - Europa 9.702
AS - Asia 8.057
SA - Sud America 989
AF - Africa 251
OC - Oceania 100
Continente sconosciuto - Info sul continente non disponibili 11
Totale 33.008
Nazione #
US - Stati Uniti d'America 13.513
IT - Italia 3.455
SG - Singapore 2.736
GB - Regno Unito 2.239
CN - Cina 1.919
HK - Hong Kong 979
DE - Germania 802
VN - Vietnam 779
SE - Svezia 769
BR - Brasile 712
FI - Finlandia 523
FR - Francia 413
RU - Federazione Russa 330
UA - Ucraina 308
TR - Turchia 248
BD - Bangladesh 244
IN - India 232
KR - Corea 223
CA - Canada 209
ID - Indonesia 147
NL - Olanda 140
BG - Bulgaria 124
JP - Giappone 103
MX - Messico 98
AR - Argentina 91
ES - Italia 87
ZA - Sudafrica 87
AU - Australia 79
PL - Polonia 79
IQ - Iraq 67
IE - Irlanda 65
LT - Lituania 64
EG - Egitto 55
PK - Pakistan 50
IR - Iran 48
DK - Danimarca 46
VE - Venezuela 39
AT - Austria 37
CH - Svizzera 37
BE - Belgio 36
CO - Colombia 36
MY - Malesia 36
CZ - Repubblica Ceca 32
BZ - Belize 31
AE - Emirati Arabi Uniti 30
EC - Ecuador 30
CL - Cile 23
SA - Arabia Saudita 22
PH - Filippine 21
TW - Taiwan 21
NZ - Nuova Zelanda 20
RO - Romania 20
KE - Kenya 19
IL - Israele 18
PE - Perù 17
PY - Paraguay 16
JO - Giordania 15
MA - Marocco 15
TH - Thailandia 15
BO - Bolivia 14
UZ - Uzbekistan 14
GR - Grecia 13
NP - Nepal 13
PT - Portogallo 13
RS - Serbia 13
TN - Tunisia 13
DZ - Algeria 12
AL - Albania 10
KW - Kuwait 10
UG - Uganda 10
CR - Costa Rica 9
ET - Etiopia 9
EU - Europa 9
AZ - Azerbaigian 7
CY - Cipro 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
KZ - Kazakistan 6
AM - Armenia 5
EE - Estonia 5
LB - Libano 5
NG - Nigeria 5
OM - Oman 5
PA - Panama 5
SI - Slovenia 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
CI - Costa d'Avorio 4
HN - Honduras 4
LV - Lettonia 4
MD - Moldavia 4
NI - Nicaragua 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
BY - Bielorussia 3
GA - Gabon 3
GE - Georgia 3
GH - Ghana 3
GT - Guatemala 3
Totale 32.936
Città #
Singapore 1.854
Santa Clara 1.556
Southend 1.483
Ashburn 1.377
Hong Kong 943
San Jose 900
Chandler 800
Fairfield 777
Woodbridge 571
Houston 516
Hefei 471
Jacksonville 470
Dearborn 448
Nyköping 418
Helsinki 399
Beijing 385
London 348
Seattle 293
Milan 287
Ann Arbor 285
Wilmington 278
New York 276
Council Bluffs 267
Rome 247
Ho Chi Minh City 245
Cambridge 237
Los Angeles 236
The Dalles 213
Seoul 206
Munich 200
Hanoi 159
Bologna 154
Princeton 127
Lauterbourg 123
Chicago 121
Sofia 110
Frankfurt am Main 107
Jakarta 99
San Diego 99
Izmir 98
Naples 98
Eugene 97
Modena 97
Moscow 96
Buffalo 95
Shanghai 94
Bremen 92
Dallas 88
Orem 82
São Paulo 81
Redwood City 79
Montreal 62
Tokyo 62
Turin 59
Boardman 58
Florence 57
Johannesburg 56
Columbus 55
Warsaw 51
Verona 49
Fremont 48
Phoenix 45
Toronto 45
Chennai 42
Dublin 41
Las Vegas 40
Bari 39
Poplar 37
Salt Lake City 37
Cairo 36
Da Nang 36
Denver 35
Palermo 34
Turku 34
Dong Ket 33
Belize City 31
Brooklyn 31
Des Moines 31
Falls Church 31
Atlanta 30
Haiphong 30
Mexico City 30
Redondo Beach 30
Manchester 29
Albuquerque 28
Guangzhou 28
Nuremberg 28
Rio de Janeiro 27
Boston 26
Padova 26
Parma 26
Amsterdam 25
Brno 25
Portsmouth 25
Brescia 24
Brussels 24
Norwalk 24
Ottawa 24
Reggio Emilia 24
Stockholm 24
Totale 20.954
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.168
Switching From Glargine to Degludec: The Effect on Metabolic Control and Safety During 1-Year of Real Clinical Practice in Children and Adolescents With Type 1 Diabetes 647
COMPLICANZE MACROVASCOLARI E MORTALITÀ NEL DIABETE TIPO 1 484
Lactobacillus reuteri oral administration improves periodontal disease in children and adolescents with type 1 diabetes 483
IPERTENSIONE IN BAMBINI ED ADOLESCENTI AFFETTI DA DIABETE DI TIPO 1: ALTA PREVALENZA IDENTIFICATA TRAMITE L’UTILIZZO DEL MONITORAGGIO PRESSORIO AMBULATORIALE 419
Accuracy of SenseWear Pro2 armband to predict resting energy expenditure in childhood obesity. 390
The Effect of GnRH-Analogue Therapy on the Quality of Life of Patients with Central Precocious Puberty and their Families 385
IMPATTO DELLA TERAPIA CON ANALOGO DEL GNRH SULLA QUALITÀ DELLA VITA DEI PAZIENTI CON CPP E DELLE LORO FAMIGLIE 379
THE IMPACT OF SENSOR-AUGMENTED INSULIN PUMP (SAP) THERAPY ON QUALITY OF LIFE (QOL) IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (T1D) AND THEIR PARENTS 378
Long-term effects on growth, development, and metabolism of ALL treatment in childhood 378
Endocrine and metabolic complications in children and adolescents with Sickle Cell Disease: An Italian cohort study 376
CONSEGUENZE METABOLICHE A BREVE E LUNGO TERMINE IN PAZIENTI CON PUBERTÀ PRECOCE CENTRALE TRATTATI CON GNRHA IN ETÀ EVOLUTIVA: STUDIO LONGITUDINALE MONOCENTRICO 375
Longitudinal evaluation of endothelial function in children and adolescents with type 1 diabetes mellitus: a long term follow up study. 373
Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study 365
A 1-year long-term study on efficacy and safety of degludec in children and adolescents with type 1 diabetes 356
L’ipercolesterolemia familiare: terapia farmacologica 337
Approaches to dyslipidemia treatment in children and adolescents 333
Effect of Weight Loss on Markers of Inflammation and Endothelial Function in Childhood Obesity 333
VALUTAZIONE AUXO-ENDOCRINOLOGICA DEI PAZIENTI AFFETTI DA SICKLE CELL DISEASE (SCD): DATI PRELIMINARI 314
COVID-19 and Type 1 Diabetes: Concerns and Challenges 303
QUALITÀ DI VITA E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 E NEI LORO GENITORI PRIMA E DOPO IL LOCKDOWN PER COVID-19. 301
Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature 300
EFFICACIA E SICUREZZA DI DEGLUDEC NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1 299
Efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes 297
High prevalence of hypertension in children and adolescents with type 1 diabetes identified through the 24 hours ambulatory blood pressure monitoring 295
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. 295
Un dolore che sveglia di notte [Pain that wakes you up at night...] 295
Basi genetiche ed aspetti terapeutici delle ipercolesterolemie familiari 290
Endocrine and Metabolic Complications in Children and Adolescents with Sickle Cell Disease: An Italian Cohort Study 289
Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic 285
Health-related quality of life and metabolic control in young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown 285
Occhio alla macrorchidia! 281
Longitudinal study of the endothelial function in children and adolescents affected by type 1 diabetes mellitus 280
Health-Related Quality of Life and Metabolic Control in Immigrant and Italian Children and Adolescents with Type 1 Diabetes and in their Parents 280
Endocrine Disrupting Chemicals and Type 1 Diabetes 277
Lipide profile, antioxidant factors and endothelial function in children and adolescent with type 1 diabetes mellitus 276
Hypercholesterolemia in Childhood 272
Markers of Inflammation and Endothelial Dysfunction in Young Survivors from Acute Lymphoblastic Leukemia 270
A new device for measuring resting energy expenditure in severely obese children and adolescents with and without non-alcoholic fatty liver disease. 269
Natural history of congenital hypothyroidism in the last two decades: what is changing? Experience of a single tertiary Italian paediatric centre 268
Elevata incidenza di Diabete tipo 1 tra i bambini di famiglie migranti provenienti dal Nord Africa nella regione Emilia Romagna. 266
Efficacy and Safety of Degludec in Children and Adolescents with Type 1 Diabetes 265
Novel insights on the treatment of hypercholesterolemia 263
Prevalence and risk factors for microalbuminuria in children and adolescents with type 1 diabetes: long-term experience of a single centre 263
Auxological data and glycemic control in children and adolescents with type 1 diabetes 2-years after the COVID-19 pandemic 262
Can inflammatory marker levels help in detecting early complications of childhood obesity? 261
Efficacy of telemedicine in patients with type 1 diabetes over the second year by the COVID-19 pandemic spread 257
Endothelial function in adolescents with type 1 diabetes mellitus (TIDM) [Funzione endoteliale in adolescenti con diabete di tipo 1], 257
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 257
High g-glutamyl-transferase fractions as new markers to identify non-alcoholic fatty liver disease in childhood obesity 257
Adrenal Hypoplasia Seemingly First as a Primary Hypoaldosteronism 256
A comparative study on the incidence of type 1 diabetes mellitus between children of North African migrants and Italian children in Emilia-Romagna region, Italy 255
Isolated hypoaldosteronism as first sign of X-linked adrenal hypoplasia congenita caused by a novel mutation in NR0B1/DAX-1 gene: a case report 251
Evaluation of Bone Mineral Density in a Cohort of Children with Growth Hormone Deficiency 250
Iper CPKemia, non solo miopatie 249
A Novel Mutation in the TITF1 Gene in a Child with Benign Hereditary Chorea 243
Study of inflammations' markers and insulin resistance in obese children and adolescents with and without non-alcoholic fatty liver disease. 242
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 241
Le merendine sono tutte uguali? Quale colazione per i bambini?. 240
Anticancer innovative therapy congress: Highlights from the 10th anniversary edition 240
Obesity and craniopharyngioma. 239
Mi presento, senza tosse– amyco plasma 238
High levels of serum perfluorinated compounds in children and adolescents with endocrine autoimmune disease 238
Quality of life in children and adolescents with type 1 diabetes and coeliac disease. 237
Arresto di crescita nei primi mesi di vita: quando l’ipolipidemia e la steatorrea fanno diagnosi. 235
EFFETTI DI UN ANNO DI PANDEMIA COVID-19 SU PARAMETRI AUXOLOGICI E CONTROLLO METABOLICO NEI BAMBINI ED ADOLESCENTI CON DIABETE DI TIPO 1. 235
Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. 233
Central Precocious Puberty in Cerebral Palsy 233
High Levels of Perfluorooctane Sulfonate in Children at the Onset of Diabetes 232
Incidental pituitary adenoma detection in two patients affected by Williams Syndrome: only a coincidence? 232
Uso delle gonadotropine urinarie per la valutazione del profilo minipuberale in neonati e lattanti di sesso maschile 231
Storia naturale dell’ipotiroidismo congenito: cosa è cambiato negli ultimi vent’anni? 229
Ten-Year Longitudinal Study of Thyroid Function in Children with Down's Syndrome 226
Malattia celiaca e patologie endocrine autoimmuni 221
Evaluation of the quality of life in children and adolescents with type 1 diabetes, coeliac disease and healthy controls. 214
Nutrizione e diabete: punti fermi e spunti di riflessione 214
Crescita e malattia celiaca 210
Circulating miR146a and 486-5p are Altered in Obese Children with and Without Non-Alcoholic Fatty LiverDisease (NAFLD) and Correlate with Abdominal Fat and BMI 208
Torcicollo A Tuttalè! (Note) Coccolini, E.a, Bruzzi, P.b, Bergonzini, P.b, Iughetti, L.ab 207
Obesity in patients with acute lymphoblastic leukemia in childhood. 207
Diagnosi genetica e valutazione della funzione endoteliale in adolescenti affetti da ipercolesterolemia familiare. 206
The Role of 24-h Ambulatory Blood Pressure Monitoring in Children and Adolescents with Type 1 Diabetes: Early Experience of a Single Centre 204
Longitudinal study of endothelial function in children with familial hypercholesterolemia. 204
Human Placenta-Derived Mesenchymal Stem Cells: A Novel Protocol for Pancreatic Differentiation 199
The rehabilitation of children and adolescents with severe or medically complicated obesity: an ISPED expert opinion document 199
Metabolic Assessment in Children with GH Deficiency Before, During, and After Human GH Replacement Therapy 198
Usefulness of CGM with iPro2 in children with T1DM and correlations between Glucose Variability and metabolic control 198
Efficacy, safety and tolerability of statin therapy in adolescents with familial hypercholesterolaemia 197
Hypercholesterolemia in Childhood: How the Response to Diet could Lead to Diagnosis. Lesson from a Case-Report 195
Malattia celiaca, una rivisitazione patogenetica e clinica. 193
Copy Number Variation Analysis Increases the Number of Candidate Loci Associated with Pediatric Obesity 189
The impact of diabetes and celiac disease in the quality of life in children and adolescents. 188
Early-life exposure to phthalates in a population of infants from the north of Italy: characterization and time trends 187
The Risk of Metabolic Syndrome among Dyslipidemic Children and Adolescents 187
Longitudinal study of endothelial function in children with type 1 diabetes mellitus 186
The Metabolic Negative Effect of Gonadotropin-Releasing Hormone Agonist Therapy in Childhood: Is it Short-Term and Reversible? 184
Usefulness of serological antibodies assays to better evaluate the prevalence of SARS-CoV-2 infection in youths with type 1 diabetes 184
Effects of 1-year COVID-19 pandemic on auxological parameters and metabolic control in young patients with type 1 diabetes 182
Obesity in adolescence: Its prevention and psycho-social aspects [Prevenzione e aspetti psico-sociali dell'obesità in età evolutiva] 181
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 180
Totale 27.715
Categoria #
all - tutte 111.504
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.504


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021142 0 0 0 0 0 0 0 0 0 0 0 142
2021/20222.269 74 211 143 199 171 139 105 127 213 189 437 261
2022/20232.998 314 281 212 256 373 376 104 278 324 106 194 180
2023/20242.454 136 133 162 246 383 272 168 282 96 100 193 283
2024/20256.443 199 133 167 426 1.090 1.010 569 376 898 323 513 739
2025/202611.089 734 347 757 1.248 1.822 863 1.685 501 961 1.082 867 222
Totale 33.370